PDF
Neoadjuvant immunotherapy: new horizon for lymph node preservation
Nian-Nian Zhong1, Bing Liu1,2(
), Lin-Lin Bu1,2()
PDF
Neoadjuvant immunotherapy: new horizon for lymph node preservation
), Lin-Lin Bu1,2()cancer treatment / immunotherapy / lymph node / organ preservation / T cell / treatment de-escalation
| 1 | MK Rahim, TLH Okholm, KB Jones, et al. Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell. 2023;186(6):1127-1143. .e18. |
| 2 | LM Cao, NN Zhong, ZZ Li, et al. Lymph node metastasis in oral squamous cell carcinoma: where we are and where we are going. Clin Transl Discov. 2023;3(4):e227. |
| 3 | AM Luoma, S Suo, Y Wang, et al. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. Cell. 2022;185(16):2918-2935.e29. |
| 4 | MH Spitzer, Y Carmi, NE Reticker-Flynn, et al. Systemic immunity is required for effective cancer immunotherapy. Cell. 2017;168(3):487-502. .e15. |
| 5 | LM Cao, NN Zhong, B Liu, et al. A surge of hope: a case of lymph node hyperplasia after oral squamous cell carcinoma neoadjuvant immunotherapy. Oral Oncol. 2023;147:106613. |
/
| 〈 |
|
〉 |
AI Summary
